Please login to the form below
Axon welcomes four new hires to its PR and med comms teams
Christopher Goddard, Lisa Seukeran, Aggie Popowicz and Priya Talluri join the agency
London, UK-based healthcare communications agency, Axon has bolstered its PR and med comms team with the addition of four new hires.
Christopher Goddard (pictured) joins Axon as its new programme manager for the group’s PR team, following a a background in journalism, serving 90TEN and Havas Life Medicom.
Alongside Goddard, Lisa Seukeran, who joins from Four Health Communications, also takes on a programme manager role.
Additionally, Aggie Popowicz joins as a programme executive following a role in market research.
Meanwhile, Priya Talluri has joined the group as a medical writer, and has previously served CDM London, Hamell, and the NHS.
Miranda Dini, managing partner of Axon, said: “We’re delighted to see this success continue into the second half of 2017 thanks to the commitment and drive our team brings into the office every day.
“I’m very much looking forward to seeing what the rest of the year has in store.”
Subscribe to our email news alerts
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
-
Pharmacovigilance Manager
- Highly competitive salary
-
Pharmacovigilance Project Lead
- Highly competitive salary
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
-
Technical Sales Representative
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
- Novo Nordisk suspended from ABPI over ‘serious’ code of practice breaches
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- LEO Pharma enters clinical trial partnership with ICON
- Results for Astellas’ non-hormonal menopause drug published in The Lancet
- Roche’s Polivy backed by FDA Advisory Committee for lymphoma therapy
- Pfizer pays Royalty Pharma $475m following US approval of migraine nasal spray
- How to create content for health professionals
- Sanofi to cut US insulin prices by up to 78% in January 2024
- Pfizer and Astellas’ Xtandi shows promise in phase 3 prostate cancer study
- 2023 PM Society Awards – winners announced
- Next congress, please: making the most of virtual pharmaceutical congresses
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- Locus Biosciences announces first patient treated in urinary tract infection trial
- A relentless commitment to neuroscience
- AstraZeneca announces major expansion of Canadian research footprint
- BMS will not launch cancer drug Opdualag in Germany due to pricing pressures
- Neurodiversity and healthcare communications – do we know enough and do we do enough?
PMHub
Dovetail
We’re a specialist health consultancy that supports companies, healthcare professionals and patients to work hand in hand with a common...
Latest intelligence
- DIGITAL EXPERIENCES: LEARNINGS FROM OUTSIDE PHARMA
- It’s long been the case that pharma lags behind other industries when it comes to digital adoption and engagement. So, what can we learn from these other industries, and how...
- WHY ARE PATIENT SUPPORT PROGRAMMES NOT WORKING?
- By offering patients knowledge, skills and confidence, they empower patients to be more actively involved in their health. Holistic support can help tackle adherence, mental health or anything else patients...
- THE EVOLVING ROLE OF PROCUREMENT?
- Procurement is evolving to reinforce its position as a strategic enabler of company growth. How can agency partners organisations to realise this?...
